FDA’s Good Reprint Practices Guidance
Medical journals may soon become the pharmaceutical industry's newest physician marketing partner. This article summarizes some of the pros and cons of FDA's Good Reprint Practices Guidance and presents preliminary results of a reader survey on the topic.
Helping Pharma eMarketing “Grow Up”
This article summarizes a Pharma Marketing Talk conversation with Carolina Petrini, SVP, Marketing Solutions, comScore, regarding her company's consumer e-marketing effectiveness benchmarks for the pharmaceutical industry.
Understanding the Strategic Value of MSLs
This article examines how tomorrow's MSL might be employed by Pharma and discusses the strategic movement of MSLs into the competitive intelligence space, teaching roles, strategic input to and evaluation of portfolio development, and investor relations.
Prescription Drugs and the Health 2.0 Opportunity
A review of some of the features of the eDrugSearch.com Community -- a new Health 2.0 Web site.
Pharma Marketing News Vol. 7, #2
Vol. 7, No. 2: February 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!...
Pharma Marketing News Vol. 7, #2
Welcome to the February, 2008 issue of Pharma Marketing News.
Pharma Marketing News Vol. 7, #1
Welcome to the January, 2008 issue of Pharma Marketing News.
Is It Time to End Industry Sponsored CME?
Preliminary results from a survey of Pharma Marketing News readers about their views regarding industry sponsorship of accredited CME, including views on value, bias, ACCME firewalls, and alternative means of CME support.
Pharma Marketing News – MSLs and KOL Management Reprints
Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.
Cholesterol Drug Users Discuss Their Medication
At breakfast recently in one of his favorite coffee shops, Jim Avery, professor of advertising at the University of Oklahoma, was talking with some friends who he knew had some health problems. Avery took the opportunity to turn the breakfast meeting into a little impromptu focus group. This article summarizes what he learned.
